Soume Bhattacharya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Soume Bhattacharya has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Renjini Lalitha
Paediatrics, Western University, London, Ontario, CANADA
4 shared publicationsAbdulaziz Homedi
Pediatrics, Western University, London, Ontario, Canada
2 shared publications- Andrea De La Hoz
Department of Lawson Research—Medicine, London Health Sciences Centre, London, ON N6A 5W, Canada
2 shared publications Anita Cheng
Paediatrics, Western University, London, Ontario, CANADA
2 shared publicationsBrooke Read
London Health Sciences Centre, London, Ontario, Canada
2 shared publicationsMichael R. Miller
Western University, Children's Health Research Institute London, Ontario, Canada
2 shared publications
Latest Publications
- 5 August 2026
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Early Respiratory Response to Bovine Lipid Extract Surfactant Can Predict Failure of Minimally Invasive Surfactant Therapy
Minimally invasive surfactant therapy (MIST) techniques for instillation of surfactant via a thin intratracheal catheter in a spontaneously breathing neonate with respiratory distress syndrome are being increasingly adopted worldwide. We designed this study to describe the short-term respiratory outcomes in neonates who received high-volume bovine lipid extract surfactant (BLES) at 5 mL/kg via MIST and analyze predictors of MIST failure. This was a retrospective, observational cohort study that included all neonates who received BLES via MIST between January 1, 2018 and December 31, 2023. Baseline demographic characteristics, immediate- and short-term respiratory outcomes were compared between patients with MIST success and MIST failure (defined as the need for mechanical ventilation within 7 days of procedure). Predictors of MIST failure were examined using logistic regression models. Of a total of 213 neonates, 41 (19.2%) were deemed MIST failure. Neonates with MIST failure compared with MIST success had lower mean (standard deviation [SD]) gestational age in weeks (29.0 [2.8] vs. 31.3 [3.4], p < 0.001) and lower mean birthweight (SD) (1247.2 [602] vs. 1654.1 [747] g, p <0.001). Neonates with MIST failure had higher preprocedural positive end expiratory pressures and higher oxygen needs than neonates with MIST success. On regression analysis, fraction of inspired oxygen (FiO2) at 1 hour (p = 0.049) and FiO2 at 6 hours (p = 0.03) post-MIST was identified as independent predictors of MIST failure after accounting for differences in baseline characteristics. Successful administration of high-volume surfactant via MIST, without any need of mechanical ventilation within 7 days of procedure was achieved in 80.8% of the cohort with a low MIST failure rate of 19.2%. Oxygen requirements measured at 1- and 6-hour post-MIST serve as independent predictors of MIST failure.
- 5 August 2026
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Early Respiratory Response to Bovine Lipid Extract Surfactant Can Predict Failure of Minimally Invasive Surfactant Therapy
Minimally invasive surfactant therapy (MIST) techniques for instillation of surfactant via a thin intratracheal catheter in a spontaneously breathing neonate with respiratory distress syndrome are being increasingly adopted worldwide. We designed this study to describe the short-term respiratory outcomes in neonates who received high-volume bovine lipid extract surfactant (BLES) at 5 mL/kg via MIST and analyze predictors of MIST failure. This was a retrospective, observational cohort study that included all neonates who received BLES via MIST between January 1, 2018 and December 31, 2023. Baseline demographic characteristics, immediate- and short-term respiratory outcomes were compared between patients with MIST success and MIST failure (defined as the need for mechanical ventilation within 7 days of procedure). Predictors of MIST failure were examined using logistic regression models. Of a total of 213 neonates, 41 (19.2%) were deemed MIST failure. Neonates with MIST failure compared with MIST success had lower mean (standard deviation [SD]) gestational age in weeks (29.0 [2.8] vs. 31.3 [3.4], p < 0.001) and lower mean birthweight (SD) (1247.2 [602] vs. 1654.1 [747] g, p <0.001). Neonates with MIST failure had higher preprocedural positive end expiratory pressures and higher oxygen needs than neonates with MIST success. On regression analysis, fraction of inspired oxygen (FiO2) at 1 hour (p = 0.049) and FiO2 at 6 hours (p = 0.03) post-MIST was identified as independent predictors of MIST failure after accounting for differences in baseline characteristics. Successful administration of high-volume surfactant via MIST, without any need of mechanical ventilation within 7 days of procedure was achieved in 80.8% of the cohort with a low MIST failure rate of 19.2%. Oxygen requirements measured at 1- and 6-hour post-MIST serve as independent predictors of MIST failure.
- 19 May 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (5) , e271784
Neonatal cyanosis: exploring the complexity of coexisting congenital methemoglobinaemia and pulmonary hypertension
Neonatal cyanosis is commonplace, usually from respiratory or cardiac causes. Consideration of alternative or combined aetiologies was required when a 3-hour-old term male neonate with central cyanosis, low oxygen saturation (SpO 2 ), and persistent pulmonary hypertension of the newborn (PPHN) confirmed on echocardiography, failed to respond to PPHN interventions. The high oxygen saturation gap and methemoglobin (MetHb) level of 16.2% shifted the working diagnosis to methemoglobinaemia. Possible triggering drugs were stopped and methylene blue was given without effect, prompting testing for haemoglobin variants. Though the SpO 2 remained in the mid-80s, MetHb levels decreased, pulmonary pressures normalised by day of life (DOL) 4, and he was discharged home on DOL 22. Diagnostic testing confirmed the haemoglobin F-M-Fort Ripley mutation ( HBG2 : c.277C>T), a variant that affects fetal haemoglobin only and is therefore self-limited. In this case, the concurrent presentation of PPHN and congenital methaemoglobinaemia created significant diagnostic and therapeutic challenges.
- 19 May 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (5) , e271784
Neonatal cyanosis: exploring the complexity of coexisting congenital methemoglobinaemia and pulmonary hypertension
Neonatal cyanosis is commonplace, usually from respiratory or cardiac causes. Consideration of alternative or combined aetiologies was required when a 3-hour-old term male neonate with central cyanosis, low oxygen saturation (SpO 2 ), and persistent pulmonary hypertension of the newborn (PPHN) confirmed on echocardiography, failed to respond to PPHN interventions. The high oxygen saturation gap and methemoglobin (MetHb) level of 16.2% shifted the working diagnosis to methemoglobinaemia. Possible triggering drugs were stopped and methylene blue was given without effect, prompting testing for haemoglobin variants. Though the SpO 2 remained in the mid-80s, MetHb levels decreased, pulmonary pressures normalised by day of life (DOL) 4, and he was discharged home on DOL 22. Diagnostic testing confirmed the haemoglobin F-M-Fort Ripley mutation ( HBG2 : c.277C>T), a variant that affects fetal haemoglobin only and is therefore self-limited. In this case, the concurrent presentation of PPHN and congenital methaemoglobinaemia created significant diagnostic and therapeutic challenges.
- 30 January 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (1) , e269444
From fetal cardiac axis deviation to postnatal neurovascular diagnosis: road to a diagnosis of vein of Galen malformation
- 30 January 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (1) , e269444
From fetal cardiac axis deviation to postnatal neurovascular diagnosis: road to a diagnosis of vein of Galen malformation
- 3 February 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (2) , e262127
Lung ultrasound as a clue to a rare genetic respiratory disease
- 3 February 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (2) , e262127
Lung ultrasound as a clue to a rare genetic respiratory disease
- 3 February 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (2) , e263338
Collaborative model of care facilitating early diagnosis of a rare neonatal cardiac anomaly
- 3 February 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (2) , e263338
Collaborative model of care facilitating early diagnosis of a rare neonatal cardiac anomaly
- Open Access
- 17 May 2024
- Published by Canadian Institute for Knowledge Development in Canadian Journal of Medicine
- Vol. 6 (1) , 52-61
Impact of Weather Conditions on Neonatal Transport in Ontario: A Retrospective Cohort Study
The successful realization of efficient neonatal transport is central to the regionalization of high-risk perinatal healthcare. Environmental factors such as weather conditions have the potential to impact transport services covering large temperate climatic zones. Our objective was to compare neonatal transport duration and relevant neonatal outcomes during winter versus summer seasons in distinct transport zones. This retrospective cohort study included newborns transported within Southwestern Ontario between January 2014 to December 2022. The serviced clinical network was divided into 4 zones based on geographical location. Transport details, patient baseline demographics, Transport Risk Index of Physiologic Stability V2 (TRIPS-II) scores, and clinically relevant outcomes were recorded. Winter (November-March) versus summer (May-September) parameters were compared within each zone. 960 transports were analyzed; 503 in summer, and 457 in winter. Baseline demographic characteristics were comparable between seasons within zones. In Zone 1, net transport time (minutes) was longer in winter versus summer (p = .019). In Zone 2, transport times were comparable; however, speed (km/min) was slower in winter versus summer (p=0.020). In Zone 3 (the Snow Belt), mean (SD) net transport times were approximately 60 minutes longer in winter versus summer [438.2(93.0) vs. 377.3(104.0), p < .001]. In Zone 4, transport times were similar between seasons. TRIPS-II scores, mortality, and major morbidity rates were comparable between seasons across all zones. This large study showed that while neonatal transport services were significantly impacted in the winter, there were no negative effects on post-transport stability, mortality, or major morbidity. Evaluation of this data might inform future service modelling.
- 17 May 2024
- Published by Canadian Institute for Knowledge Development in Canadian Journal of Medicine
- Vol. 6 (1) , 52-61
Open AccessImpact of Weather Conditions on Neonatal Transport in Ontario: A Retrospective Cohort Study
The successful realization of efficient neonatal transport is central to the regionalization of high-risk perinatal healthcare. Environmental factors such as weather conditions have the potential to impact transport services covering large temperate climatic zones. Our objective was to compare neonatal transport duration and relevant neonatal outcomes during winter versus summer seasons in distinct transport zones. This retrospective cohort study included newborns transported within Southwestern Ontario between January 2014 to December 2022. The serviced clinical network was divided into 4 zones based on geographical location. Transport details, patient baseline demographics, Transport Risk Index of Physiologic Stability V2 (TRIPS-II) scores, and clinically relevant outcomes were recorded. Winter (November-March) versus summer (May-September) parameters were compared within each zone. 960 transports were analyzed; 503 in summer, and 457 in winter. Baseline demographic characteristics were comparable between seasons within zones. In Zone 1, net transport time (minutes) was longer in winter versus summer (p = .019). In Zone 2, transport times were comparable; however, speed (km/min) was slower in winter versus summer (p=0.020). In Zone 3 (the Snow Belt), mean (SD) net transport times were approximately 60 minutes longer in winter versus summer [438.2(93.0) vs. 377.3(104.0), p < .001]. In Zone 4, transport times were similar between seasons. TRIPS-II scores, mortality, and major morbidity rates were comparable between seasons across all zones. This large study showed that while neonatal transport services were significantly impacted in the winter, there were no negative effects on post-transport stability, mortality, or major morbidity. Evaluation of this data might inform future service modelling.
- Open Access
- 9 March 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (3) , 618
Application of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study
Minimally invasive surfactant therapy (MIST) has emerged as a preferred method of surfactant delivery. Pioneers of this technique have described the use of direct laryngoscopy (DL) for MIST. With the increasing application of video laryngoscopy (VL) for neonatal airway management, it is speculated that MIST techniques can be adapted for use with VL. Objective: To compare procedural success, operator ease of use, and complication of MIST using VL vs. MIST using DL. Methods: This was a retrospective, observational cohort study conducted at a tertiary-level neonatal intensive care unit after obtaining ethical approval. We included neonates who received MIST between 1 October 2020 and 31 October 2022. Baseline demographic characteristics, along with procedural data, were collected. Primary outcome measures included the overall procedural success rate, the need for multiple attempts, and the total number of attempts. Secondary outcome measures included the occurrence of adverse events, the need for a second dose of surfactant, and the need for intubation within 7 days of the procedure. Means and SDs, independent t-tests, frequencies, and chi-square were used as appropriate. p-values < 0.05 were considered statistically significant. Results: Of the 79 neonates included, 37 neonates received MIST via VL, while 42 received MIST via DL. The median gestational age was lower in the VL group at 29.0 weeks vs. 30.5 weeks (p = 0.011) in the DL group. The median birthweight in the VL group was 1260 g, IQR (1080, 1690), which was significantly lower than the DL group, which was 1575 g, IQR (1220, 2251), p = 0.028. Purpose-built catheter use was higher in the DL group. The overall procedural success was similar between groups. The need for multiple attempts was lower with VL in comparison to DL [4 (11%) vs. 13 (31%); p = 0.034)] at the univariate level but not significant at multivariate analysis (p = 0.131). Procedural complications, the need for a second dose of surfactant, the need for mechanical ventilation post-MIST, and operator ease of use were similar. User comments emphasized the value of VL in providing real-time visual information to confirm catheter placement and guide operators/trainees. Conclusion: Overall, in our cohort, despite VL being a more recently adapted technology used more in smaller, sicker, and more premature neonates, procedural success, complications, and operator ease of use for MIST using VL and DL were comparable. Our findings show the successful application of VL for MIST and suggest procedural advantages that might facilitate universal adoption.
- 9 March 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (3) , 618
Open AccessApplication of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study
Minimally invasive surfactant therapy (MIST) has emerged as a preferred method of surfactant delivery. Pioneers of this technique have described the use of direct laryngoscopy (DL) for MIST. With the increasing application of video laryngoscopy (VL) for neonatal airway management, it is speculated that MIST techniques can be adapted for use with VL. Objective: To compare procedural success, operator ease of use, and complication of MIST using VL vs. MIST using DL. Methods: This was a retrospective, observational cohort study conducted at a tertiary-level neonatal intensive care unit after obtaining ethical approval. We included neonates who received MIST between 1 October 2020 and 31 October 2022. Baseline demographic characteristics, along with procedural data, were collected. Primary outcome measures included the overall procedural success rate, the need for multiple attempts, and the total number of attempts. Secondary outcome measures included the occurrence of adverse events, the need for a second dose of surfactant, and the need for intubation within 7 days of the procedure. Means and SDs, independent t-tests, frequencies, and chi-square were used as appropriate. p-values < 0.05 were considered statistically significant. Results: Of the 79 neonates included, 37 neonates received MIST via VL, while 42 received MIST via DL. The median gestational age was lower in the VL group at 29.0 weeks vs. 30.5 weeks (p = 0.011) in the DL group. The median birthweight in the VL group was 1260 g, IQR (1080, 1690), which was significantly lower than the DL group, which was 1575 g, IQR (1220, 2251), p = 0.028. Purpose-built catheter use was higher in the DL group. The overall procedural success was similar between groups. The need for multiple attempts was lower with VL in comparison to DL [4 (11%) vs. 13 (31%); p = 0.034)] at the univariate level but not significant at multivariate analysis (p = 0.131). Procedural complications, the need for a second dose of surfactant, the need for mechanical ventilation post-MIST, and operator ease of use were similar. User comments emphasized the value of VL in providing real-time visual information to confirm catheter placement and guide operators/trainees. Conclusion: Overall, in our cohort, despite VL being a more recently adapted technology used more in smaller, sicker, and more premature neonates, procedural success, complications, and operator ease of use for MIST using VL and DL were comparable. Our findings show the successful application of VL for MIST and suggest procedural advantages that might facilitate universal adoption.
- Open Access
- 17 October 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (20) , 11380
Improved Cardiac Performance with Dexamethasone Therapy in Premature Neonates: Novel Insights Using Serial Echocardiographic Assessments
(1) Background: dexamethasone is used for the prevention and treatment of chronic lung disease (CLD) in premature neonates, and its impact on cardiac performance and pulmonary vascular resistance has not been well studied. (2) Methods: eligible neonates of p = 0.025), tricuspid annular plane systolic excursion (TAPSE 0.65 cm vs. 0.70 cm, p = 0.013), and RV S’ (7.18 vs. 8.56, p = 0.05). The left ventricular (LV) ejection fraction was similar but with a significant increase in the LV S’ (4.77 vs. 6.01, p = 0.006). A longitudinal analysis at three time points showed a significant increase in RV FAC (0.02 units 95% CI (0.00–0.04), p = 0.037), TAPSE (0.09 units 95% CI (0.06–0.13), p < 0.001), RV S’ (0.97 units (95% CI = 0.11–1.84), p = 0.028), a reduction in the eccentricity index (0.07 units 95% CI (−0.14–−0.01), p = 0.030), and an increase in the LV S’ (0.56 units (95% CI = 0.18–0.94)). (4) Conclusion: The use of postnatal dexamethasone for the prevention/treatment of CLD in premature neonates resulted in an expected improvement in respiratory status along with a significant improvement in the echocardiographic measures of biventricular heart performance.
- 17 October 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (20) , 11380
Open AccessImproved Cardiac Performance with Dexamethasone Therapy in Premature Neonates: Novel Insights Using Serial Echocardiographic Assessments
(1) Background: dexamethasone is used for the prevention and treatment of chronic lung disease (CLD) in premature neonates, and its impact on cardiac performance and pulmonary vascular resistance has not been well studied. (2) Methods: eligible neonates of p = 0.025), tricuspid annular plane systolic excursion (TAPSE 0.65 cm vs. 0.70 cm, p = 0.013), and RV S’ (7.18 vs. 8.56, p = 0.05). The left ventricular (LV) ejection fraction was similar but with a significant increase in the LV S’ (4.77 vs. 6.01, p = 0.006). A longitudinal analysis at three time points showed a significant increase in RV FAC (0.02 units 95% CI (0.00–0.04), p = 0.037), TAPSE (0.09 units 95% CI (0.06–0.13), p < 0.001), RV S’ (0.97 units (95% CI = 0.11–1.84), p = 0.028), a reduction in the eccentricity index (0.07 units 95% CI (−0.14–−0.01), p = 0.030), and an increase in the LV S’ (0.56 units (95% CI = 0.18–0.94)). (4) Conclusion: The use of postnatal dexamethasone for the prevention/treatment of CLD in premature neonates resulted in an expected improvement in respiratory status along with a significant improvement in the echocardiographic measures of biventricular heart performance.
- 15 September 2023
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 41 (S 01) , e2703-e2709
Impact of Targeted Neonatal Echocardiography on Patent Ductus Arteriosus Management in a Canadian Tertiary Care Neonatal Unit: A Retrospective Cohort Study
Objective Comprehensive assessment of hemodynamic significance of a patent ductus arteriosus (PDA) is a common indication to perform targeted neonatal echocardiography (TNE). Impact of implementation of such an assessment on PDA management decisions remains to be reported. The objective of this study is to compare PDA-related hemodynamic information and PDA treatment decisions before and after introduction of TNE service. Study Design This was a retrospective cohort study at a tertiary level neonatal intensive care unit in Southwestern Ontario. We investigated two time periods: Epoch-1 (non-TNE 2013–2016) versus Epoch-2 (TNE 2018–2021). We included neonates < 32 weeks with PDA. Data on baseline clinical characteristics, PDA-related echocardiographic parameters, PDA treatment details, and relevant long-term outcomes were collected. Primary outcome was defined as PDA treatment rates and need for multiple courses. Secondary outcomes included availability of PDA hemodynamic data and neonatal mortality/morbidity (PDA-related) Results A total of 275 neonates were included. A total of 162 were assessed by conventional echocardiography in Epoch-1, whereas 113 were assessed by TNE in Epoch-2. Baseline clinical characteristics were similar. Epoch-2 had more echocardiographic assessments per patient of 2.7 (±1.8) versus 1.9 (± 1.3), p < 0.001 in Epoch1. The mean postnatal age at first echocardiographic assessment was higher in Epoch-2 (12.7 days [ ± 14.6]) than in Epoch-1 (7.9 days [ ± 10.4]), p < 0.001. Comprehensive hemodynamic assessment of PDA-related echocardiographic parameters such as PDA size, shunt pattern, effect on systemic circulation, and pulmonary circulation were higher in Epoch-2. Overall, PDA treatment rates were comparable in the two time periods. The use of multiple courses of treatment was higher in Epoch-1 than in Epoch-2 (47.8 vs. 31.7%, p = 0.047). In Epoch-1, neonates received PDA treatment earlier than in Epoch-2. Conclusion With the implementation of the TNE service, increased echocardiographic evaluations per patient were completed with availability of more comprehensive hemodynamic information about PDA. PDA treatment rates were similar in the two epochs, but need for multiple courses were less in TNE era. Key Points
- 15 September 2023
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 41 (S 01) , e2703-e2709
Impact of Targeted Neonatal Echocardiography on Patent Ductus Arteriosus Management in a Canadian Tertiary Care Neonatal Unit: A Retrospective Cohort Study
Objective Comprehensive assessment of hemodynamic significance of a patent ductus arteriosus (PDA) is a common indication to perform targeted neonatal echocardiography (TNE). Impact of implementation of such an assessment on PDA management decisions remains to be reported. The objective of this study is to compare PDA-related hemodynamic information and PDA treatment decisions before and after introduction of TNE service. Study Design This was a retrospective cohort study at a tertiary level neonatal intensive care unit in Southwestern Ontario. We investigated two time periods: Epoch-1 (non-TNE 2013–2016) versus Epoch-2 (TNE 2018–2021). We included neonates < 32 weeks with PDA. Data on baseline clinical characteristics, PDA-related echocardiographic parameters, PDA treatment details, and relevant long-term outcomes were collected. Primary outcome was defined as PDA treatment rates and need for multiple courses. Secondary outcomes included availability of PDA hemodynamic data and neonatal mortality/morbidity (PDA-related) Results A total of 275 neonates were included. A total of 162 were assessed by conventional echocardiography in Epoch-1, whereas 113 were assessed by TNE in Epoch-2. Baseline clinical characteristics were similar. Epoch-2 had more echocardiographic assessments per patient of 2.7 (±1.8) versus 1.9 (± 1.3), p < 0.001 in Epoch1. The mean postnatal age at first echocardiographic assessment was higher in Epoch-2 (12.7 days [ ± 14.6]) than in Epoch-1 (7.9 days [ ± 10.4]), p < 0.001. Comprehensive hemodynamic assessment of PDA-related echocardiographic parameters such as PDA size, shunt pattern, effect on systemic circulation, and pulmonary circulation were higher in Epoch-2. Overall, PDA treatment rates were comparable in the two time periods. The use of multiple courses of treatment was higher in Epoch-1 than in Epoch-2 (47.8 vs. 31.7%, p = 0.047). In Epoch-1, neonates received PDA treatment earlier than in Epoch-2. Conclusion With the implementation of the TNE service, increased echocardiographic evaluations per patient were completed with availability of more comprehensive hemodynamic information about PDA. PDA treatment rates were similar in the two epochs, but need for multiple courses were less in TNE era. Key Points
- Open Access
- 23 June 2023
- Published by Canadian Society of Respiratory Therapists in Canadian Journal of Respiratory Therapy
- Vol. 59 (1) , 137-144
Purpose built catheters for minimally invasive surfactant therapy: Experience from a Canadian tertiary level neonatal intensive care unit
Background: Minimally invasive surfactant therapy (MIST), a method of surfactant delivery via a thin catheter during spontaneous breathing, is an increasingly popular alternative to intubation and surfactant administration. Recently, purpose-built catheters for MIST received regulatory approval in Canada and became available for use. However, procedural success and user experience with such catheters have not been described. Methods: This retrospective cohort study included neonates who received MIST using purpose-built catheters between January 1, 2021, and March 31, 2022. Two types of purpose-built catheters were used in this period - SurfCath™ and BLEScath™. Procedural success, number of attempts, and adverse events in neonates receiving MIST via the two catheters were compared using chi-square or Fisher’s tests. User experience was described using an ease-of-use scale. Results: Thirty-seven neonates met eligibility criteria; 22 received MIST via SurfCath™, whereas 15 received MIST via BLEScath™. Success rates were 91% in SurfCath™ and 93% in BLEScath™ (P> 0.994). Failed attempts were lower in SurfCath™ (23%) in comparison to BLEScath™ (33%), but the difference was not statistically significant (P=0.708). Among operators, 90% found SurfCath™ very easy/relatively easy to use compared to 43% of users reflecting the same degree of use with BLEScath™ (P=.021). There was no difference in adverse events. Conclusion: This is the first study in Canada to report MIST with purpose-built catheters. Overall, the success rate was equally high with both catheters. Users subjectively reported higher ease of use with SurfCath™. Commercially available purpose-built catheters should facilitate universal adaptation of the MIST method.
- 23 June 2023
- Published by Canadian Society of Respiratory Therapists in Canadian Journal of Respiratory Therapy
- Vol. 59 (1) , 137-144
Open AccessPurpose built catheters for minimally invasive surfactant therapy: Experience from a Canadian tertiary level neonatal intensive care unit
Background: Minimally invasive surfactant therapy (MIST), a method of surfactant delivery via a thin catheter during spontaneous breathing, is an increasingly popular alternative to intubation and surfactant administration. Recently, purpose-built catheters for MIST received regulatory approval in Canada and became available for use. However, procedural success and user experience with such catheters have not been described. Methods: This retrospective cohort study included neonates who received MIST using purpose-built catheters between January 1, 2021, and March 31, 2022. Two types of purpose-built catheters were used in this period - SurfCath™ and BLEScath™. Procedural success, number of attempts, and adverse events in neonates receiving MIST via the two catheters were compared using chi-square or Fisher’s tests. User experience was described using an ease-of-use scale. Results: Thirty-seven neonates met eligibility criteria; 22 received MIST via SurfCath™, whereas 15 received MIST via BLEScath™. Success rates were 91% in SurfCath™ and 93% in BLEScath™ (P> 0.994). Failed attempts were lower in SurfCath™ (23%) in comparison to BLEScath™ (33%), but the difference was not statistically significant (P=0.708). Among operators, 90% found SurfCath™ very easy/relatively easy to use compared to 43% of users reflecting the same degree of use with BLEScath™ (P=.021). There was no difference in adverse events. Conclusion: This is the first study in Canada to report MIST with purpose-built catheters. Overall, the success rate was equally high with both catheters. Users subjectively reported higher ease of use with SurfCath™. Commercially available purpose-built catheters should facilitate universal adaptation of the MIST method.